原发性远端肾小管酸中毒的治疗与长期结局
该研究通过欧洲专业组织联系儿科和成人肾脏科医生,收集340例原发性远端肾小管酸中毒(dRTA)患者的数据,分析治疗与长期结局。结果显示多数患者成年身高正常且无CKD 5期,但82%成人患者存在CKD 2-4期,仅51%达到充分代谢控制,而充分代谢控制与更好的身高和eGFR相关。
要点
- 82%成人dRTA患者存在CKD 2-4期,但无CKD 5期。
- 仅51%患者达到充分代谢控制,与更高身高和eGFR相关。
- SLC4A1突变者肾结石更常见,ATP6V1B1突变者听力损失更常见。
核心结论
- 长期随访显示多数dRTA患者成年身高正常且无CKD 5期,但82%成人患者存在CKD 2-4期。
- 充分代谢控制与更好的身高和估算肾小球滤过率相关,但仅51%患者达到。
研究设计与样本
- 通过欧洲专业组织联系儿科和成人肾脏科医生,在线收集340例患者(29个国家,女性52%)的人口学、生化、遗传和临床数据。
主要发现
- 206例(61%)进行了突变检测,170例(83%)发现致病突变。
- 初诊年龄中位数0.5岁(范围0-54),末次随访年龄中位数11.0岁(范围0-70.0)。
- 成年身高平均标准差评分为-0.57(±1.16)。
- 儿童CKD≥2期患病率35%,成人82%;肾钙质沉着症报告率88%。
关键数值与推荐
- 碱剂处方剂量中位数1.9 mEq/kg/天(四分位距1.2-3.3)。
- 充分代谢控制(血碳酸氢盐正常且尿钙正常)见于158例(51%),在高GDP国家更常见(67% vs 23%)。
临床怎么用
- 应重视dRTA患者的长期代谢控制,以改善身高和肾功能。
- 对SLC4A1突变者关注肾结石,对ATP6V1B1突变者关注听力损失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary distal renal tubular acidosis (dRTA) is a rare disorder, and we aimed to gather data on treatment and long-term outcome. METHODS: We contacted paediatric and adult nephrologists through European professional organizations. Responding clinicians entered demographic, biochemical, genetic and clinical data in an online form. RESULTS: Adequate data were collected on 340 patients (29 countries, female 52%). Mutation testing had been performed on 206 patients (61%); pathogenic mutations were identified in 170 patients (83%). The median (range) presentation age was 0.5 (0-54) years and age at last follow-up was 11.0 (0-70.0) years. Adult height was slightly below average with a mean (SD score) of -0.57 (±1.16). There was an increased prevalence of chronic kidney disease (CKD) Stage ≥2 in children (35%) and adults (82%). Nephrocalcinosis was reported in 88%. Nephrolithiasis was more common with SLC4A1 mutations (42% versus 21%). Thirty-six percent had hearing loss, particularly in ATP6V1B1 (88%). The median (interquartile range) prescribed dose of alkali (mEq/kg/day) was 1.9 (1.2-3.3). Adequate metabolic control (normal plasma bicarbonate and normocalciuria) was achieved in 158 patients (51%), more commonly in countries with higher gross domestic product (67% versus 23%), and was associated with higher height and estimated glomerular filtration rate. CONCLUSION: Long-term follow-up from this large dRTA cohort shows an overall favourable outcome with normal adult height for most and no patient with CKD Stage 5. However, 82% of adult patients have CKD Stages 2-4. Importance of adequate metabolic control was highlighted by better growth and renal function but was achieved in only half of patients.
引用
- Lopez-Garcia SC, Emma F, Walsh SB, et al. Treatment and long-term outcome in primary distal renal tubular acidosis. Nephrol Dial Transplant. 2019. PMID: 30773598. doi:10.1093/ndt/gfy409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。